Results 141 to 150 of about 38,655 (210)

Refractory ulcerations treated with timolol due to bullous pemphigoid in the setting of chronic cutaneous graft-versus-host disease. [PDF]

JAAD Case Rep
Kumar M, Ezzeddine FL, Guggina L.
europepmc   +1 more source

Acquired hemophilia A in an elderly female with bullous pemphigoid: Case report. [PDF]

Medicine (Baltimore)
Liu Z, Xu J.
europepmc   +1 more source

Bullous eczema with hyaluronic acid deposition: A case report. [PDF]

JAAD Case Rep
Kohri N, Yatsuzuka K, Yoshida S, Nishihara K, Shiraishi K, Fujisawa Y, Muto J.   +6 more
europepmc   +1 more source

Moist verrucous plaques of the nail matrix and nail bed: A case of probable ungual pemphigoid vegetans. [PDF]

JAAD Case Rep
Ang XL, Li Y, Ang CC.
europepmc   +1 more source

Expanding the Spectrum of Bullous Pemphigoid in Skin of Color. [PDF]

Indian Dermatol Online J
De D, Mehta H.
europepmc   +1 more source

Immuno-oncologyDupilumab for bullous pemphigoid related to immune checkpoint inhibitors: a retrospective case series. [PDF]

Oncologist
Nykaza I, Moy A, Dusza SW, Moskowitz A, Iyer G, Iqbal A, Motzer R, Ilson DH, O'Cearbhaill RE, Kazi R, Defazio J, Gordon A, Markova A.   +12 more
europepmc   +1 more source

Dupilumab for bullous pemphigoid: Umbrella review of systematic reviews and meta-analyses. [PDF]

JAAD Int
Thapa M, Green B, Kasperkiewicz M.
europepmc   +1 more source

Introducing human 3D skin models as a new serological diagnostic tool for severe autoimmune bullous diseases. [PDF]

Front Immunol
Huth L, Heise R, Marquardt Y, Jansen M, Kluwig D, Schmidt MF, Albuscheit N, von Felbert V, CTC-A Translation Group, Jockenhoevel S, Huth S, Yazdi AS, Baron JM.   +12 more
europepmc   +1 more source

Bullous Pemphigoid Develops Independently of DAP12. [PDF]

Biomolecules
Pigors M, Patzelt S, Brudey M, Emtenani S, Khil'chenko S, Kamaguchi M, Reichhelm N, Parker M, Bieber K, Ludwig RJ, Schmidt E.   +10 more
europepmc   +1 more source

Effective response to high-frequency and prolonged dupilumab therapy in severe refractory bullous pemphigoid: A case study. [PDF]

Hum Vaccin Immunother
Jiang X, Chen L, Zhu Y, Zhan S, Jin N, Cheng H.   +5 more
europepmc   +1 more source